ArticleCancers2024

The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the Bladder.

Alexander Tamalunas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.